Cite
HARVARD Citation
Brandes, J. et al. (2019). Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). Cephalalgia. pp. 1343-1357. [Online].